PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma

Cytokine-induced killer (CIK) cell immunotherapy represents an effective treatment strategy for treating hepatocellular carcinoma (HCC). However, the therapeutic benefits of CIK cell treatment can be influenced by differences in complex immune microenvironment between patients. Herein, we investigat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncoimmunology
Main Authors: Chen, Chang-Long, Pan, Qiu-Zhong, Zhao, Jing-Jing, Wang, Ying, Li, Yong-Qiang, Wang, Qi-Jing, Pan, Ke, Weng, De-Sheng, Jiang, Shan-Shan, Tang, Yan, Zhang, Xiao-Fei, Zhang, Hong-Xia, Zhou, Zi-Qi, Zeng, Yi-Xin, Xia, Jian-Chuan
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2016
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5006896/
https://ncbi.nlm.nih.gov/pubmed/27622026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1176653
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares